Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Hansen's disease
67%
Visceral Leishmaniasis
64%
African Trypanosomiasis
57%
Post-Exposure Prophylaxis
36%
Diseases
30%
Rifampicin
29%
Single Drug Dose
21%
Prevalence
20%
Arm
17%
Infection
16%
Mycobacterium leprae
13%
Health Care Cost
12%
Enzyme Linked Immunosorbent Assay
12%
Tuberculosis
12%
Health Service
12%
Drug Resistance
11%
Vector Control
11%
Leishmania donovani
10%
Cross Sectional Study
10%
Cluster Randomized Trial
10%
Observational Study
10%
Acoziborole
10%
Human immunodeficiency virus
10%
Endemic Disease
10%
Skin Biopsy
9%
Primary Health Care
9%
Multidrug Resistant Tuberculosis
8%
Case Finding
8%
Surveillance System
7%
Trypanosoma brucei
7%
Oral
7%
Rapid Diagnostic Test
7%
Mixed Infection
6%
Diagnostic Test
6%
Public Health
6%
Leishmania
6%
Drug Resistant Tuberculosis
6%
Screening Test
6%
Serological Test
6%
Real-Time Polymerase Chain Reaction
6%
Outpatient
5%
Mycobacteria
5%
Nose Smear
5%
Cutaneous Leishmaniasis
5%
Schistosomiasis
5%
Xenodiagnosis
5%
Bedaquiline
5%
Diabetes Mellitus
5%
Buruli Ulcer
5%
Tongue
5%
Immunology and Microbiology
Visceral Leishmaniasis
100%
Prevalence
41%
Infection
36%
Infectious Disease
31%
Cutaneous Leishmaniasis
24%
Leishmania donovani
24%
ELISA
24%
Mycobacterium leprae
17%
Leishmania
17%
Antigen-Antibody Interaction
14%
Leishmaniasis
14%
Real-Time Polymerase Chain Reaction
14%
Parasite
13%
Drug Resistance
12%
Immunoglobulin M
10%
Seroprevalence
10%
Arm
10%
Glycolipid
10%
Madagascar
10%
Schistosomiasis
9%
Trypanosoma
8%
Helminthiasis
7%
Recombinant Antigen
6%
Serology
6%
Titer
6%
Helminth
6%
Coinfection
6%
Trypanosoma brucei gambiense
6%
Single Nucleotide Polymorphism
5%
Phlebotominae
5%
Bacterial Load
5%
Camel
5%
Back
5%
Tongue
5%
Lineage
5%
Quantitative Reverse Transcription Polymerase Chain Reaction
5%
Whole Genome Sequencing
5%
Multidrug Resistance
5%
Mycobacteria
5%
Dromedary
5%
Patient Mobility
5%
Amplicon Sequencing
5%
Domestic Animal
5%
Human immunodeficiency virus
5%
Antibiotic Resistance
5%
Nursing and Health Professions
Visceral Leishmaniasis
62%
African Trypanosomiasis
15%
Tuberculosis
14%
Skin Leishmaniasis
14%
Miltefosine
12%
Treatment Outcome
11%
Rifampicin
10%
Primary Health Care
9%
Health Care
8%
Prevalence
7%
Diseases
6%
Adherence
5%
Health Care Personnel
5%
Leishmaniasis
5%
Cross-Sectional Study
5%
Clinical Outcome
5%
Therapy Delay
5%
Human immunodeficiency virus
5%
Dried Blood Spot Testing
5%
Glycemic Control
5%
Enzyme Linked Immunosorbent Assay
5%
Drug Resistant Tuberculosis
5%
Qualitative Research
5%
Single Drug Dose
5%
Post Exposure Prophylaxis
5%
Treatment Interruption
5%
Therapeutic Drug Monitoring
5%
Qualitative Study
5%
Mixed Infection
5%
Diabetes Mellitus
5%
